help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vegeto, E.
Right arrow Articles by McDonnell, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vegeto, E.
Right arrow Articles by McDonnell, D. P.

Molecular Endocrinology, Vol 7, 1244-1255, Copyright © 1993 by Endocrine Society


ARTICLES

Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function

E Vegeto, MM Shahbaz, DX Wen, ME Goldman, BW O'Malley and DP McDonnell
Ligand Pharmaceuticals Inc., San Diego, California 92121.

Two distinct isoforms of the human progesterone receptor (hPR-A and hPR- B) have been identified previously. They differ only in that hPR-B contains an additional 164 amino acids at the amino terminus. Among various species these two forms arise as a result of either alternate initiation of translation from the same mRNA or by transcription from alternate promoters within the same gene. In order to understand the reason for their existence, we studied the transcriptional capacity of these individual receptors and observed that their activity was influenced strongly by cell and promoter context. More surprising was the observation that in promoter and cell contexts where hPR-A was inactive, it acted as a potent trans-dominant repressor of hPR-B- mediated transcription. This event occurred at substoichiometric concentrations of hPR-A and was hormone dependent. Human PR-A was not a general repressor of ligand-mediated transcription, as it had no effect on vitamin D receptor function. Interestingly, hPR-A but not hPR-B was capable of a similar inhibition of glucocorticoid, androgen, and mineralocorticoid receptor-mediated gene transcription. This suggests a specific role for the hPR-A isoform in this regulatory process. The trans-dominant effects of hPR-A were induced also by the antiprogestins ZK112993 and ZK98299 and a DNA binding defective hPR-A mutant, suggesting that the inhibitory function of hPR-A does not require DNA binding. The dual role of hPR-A as an activator or repressor of transcription defines a potential mechanism by which cells can generate dissimilar responses to a single hormone and provides a molecular explanation for the existence of two distinct forms of the hPR.


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Mani
Progestin Receptor Subtypes in the Brain: The Known and the Unknown
Endocrinology, June 1, 2008; 149(6): 2750 - 2756.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Z. Zeng, M. C. Velarde, F. A. Simmen, and R. C.M. Simmen
Delayed Parturition and Altered Myometrial Progesterone Receptor Isoform A Expression in Mice Null for Kruppel-Like Factor 9
Biol Reprod, June 1, 2008; 78(6): 1029 - 1037.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. J. Rickard, U. T. Iwaniec, G. Evans, T. E. Hefferan, J. C. Hunter, K. M. Waters, J. P. Lydon, B. W. O'Malley, S. Khosla, T. C. Spelsberg, et al.
Bone Growth and Turnover in Progesterone Receptor Knockout Mice
Endocrinology, May 1, 2008; 149(5): 2383 - 2390.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson
Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis
Endocrinology, March 1, 2008; 149(3): 1190 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Q. Xu, N. Ohara, J. Liu, M. Amano, R. Sitruk-Ware, S. Yoshida, and T. Maruo
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells
Mol. Hum. Reprod., March 1, 2008; 14(3): 181 - 191.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Wang, E.-W. Lee, L. Zhou, P. C. K. Leung, D. D. Ross, J. D. Unadkat, and Q. Mao
Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells
Mol. Pharmacol., March 1, 2008; 73(3): 845 - 854.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. M. Salih, S. A. Salama, M. Jamaluddin, A. A. Fadl, L. J. Blok, C. W. Burger, M. Nagamani, and A. Al-Hendy
Progesterone-Mediated Regulation of Catechol-O-Methyl Transferase Expression in Endometrial Cancer Cells
Reproductive Sciences, February 1, 2008; 15(2): 210 - 220.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
M. C. Velarde, Z. Zeng, J. R. McQuown, F. A. Simmen, and R. C. M. Simmen
Kruppel-Like Factor 9 Is a Negative Regulator of Ligand-Dependent Estrogen Receptor {alpha} Signaling in Ishikawa Endometrial Adenocarcinoma Cells
Mol. Endocrinol., December 1, 2007; 21(12): 2988 - 3001.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
N. Ohara, A. Morikawa, Wei Chen, Jiayin Wang, D. A. DeManno, K. Chwalisz, and T. Maruo
Comparative Effects of SPRM Asoprisnil (J867) on Proliferation, Apoptosis, and the Expression of Growth Factors in Cultured Uterine Leiomyoma Cells and Normal Myometrial Cells
Reproductive Sciences, December 1, 2007; 14(8_suppl): 20 - 27.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kariagina, M. D. Aupperlee, and S. Z. Haslam
Progesterone Receptor Isoforms and Proliferation in the Rat Mammary Gland during Development
Endocrinology, June 1, 2007; 148(6): 2723 - 2736.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. A. Merlino, T. N. Welsh, H. Tan, L. J. Yi, V. Cannon, B. M. Mercer, and S. Mesiano
Nuclear Progesterone Receptors in the Human Pregnancy Myometrium: Evidence that Parturition Involves Functional Progesterone Withdrawal Mediated by Increased Expression of Progesterone Receptor-A
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1927 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. P. Madauss, E. T. Grygielko, S.-J. Deng, A. C. Sulpizio, T. B. Stanley, C. Wu, S. A. Short, S. K. Thompson, E. L. Stewart, N. J. Laping, et al.
A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator
Mol. Endocrinol., May 1, 2007; 21(5): 1066 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
G. Madsen, D. A. MacIntyre, S. Mesiano, and R. Smith
Progesterone Receptor or Cytoskeletal Protein?
Reproductive Sciences, April 1, 2007; 14(3): 217 - 222.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
A. Shatnawi, T. Tran, and M. Ratnam
R5020 and RU486 Act as Progesterone Receptor Agonists to Enhance Sp1/Sp4-Dependent Gene Transcription by an Indirect Mechanism
Mol. Endocrinol., March 1, 2007; 21(3): 635 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Sasaki, N. Ohara, Q. Xu, J. Wang, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
A Novel Selective Progesterone Receptor Modulator Asoprisnil Activates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Signaling Pathway in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 616 - 623.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. M White, I. Sheffer, J. Teeter, and E. M. Apostolakis
Hypothalamic progesterone receptor-A mediates gonadotropin surges, self priming and receptivity in estrogen-primed female mice
J. Mol. Endocrinol., January 1, 2007; 38(1): 35 - 50.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R. Pilka, I. Oborna, V. Lichnovsky, P. Havelka, H. Fingerova, P. Eriksson, S. Hansson, and B. Casslen
Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients
Hum. Reprod., December 1, 2006; 21(12): 3146 - 3156.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Yang, I. M. Wolf, H. Chen, S. Periyasamy, Z. Chen, W. Yong, S. Shi, W. Zhao, J. Xu, A. Srivastava, et al.
FK506-Binding Protein 52 Is Essential to Uterine Reproductive Physiology Controlled by the Progesterone Receptor A Isoform
Mol. Endocrinol., November 1, 2006; 20(11): 2682 - 2694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Brayman, J. Julian, B. Mulac-Jericevic, O. M. Conneely, D. P. Edwards, and D. D. Carson
Progesterone Receptor Isoforms A and B Differentially Regulate MUC1 Expression in Uterine Epithelial Cells
Mol. Endocrinol., October 1, 2006; 20(10): 2278 - 2291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. O'Brien, T. J. Peterson, M. H. Tong, E.-J. Lee, L. E. Pfaff, S. C. Hewitt, K. S. Korach, J. Weiss, and J. L. Jameson
Estrogen-induced Proliferation of Uterine Epithelial Cells Is Independent of Estrogen Receptor {alpha} Binding to Classical Estrogen Response Elements
J. Biol. Chem., September 8, 2006; 281(36): 26683 - 26692.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. Shao, E. Egecioglu, B. Weijdegard, K. Ljungstrom, C. Ling, J. Fernandez-Rodriguez, and H. Billig
Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
J. Endocrinol., September 1, 2006; 190(3): 857 - 870.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Q. Xu, N. Ohara, W. Chen, J. Liu, H. Sasaki, A. Morikawa, R. Sitruk-Ware, E. D.B. Johansson, and T. Maruo
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells
Hum. Reprod., September 1, 2006; 21(9): 2408 - 2416.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
W. Pei, C. G Bellows, Y. Jia, and J. N M Heersche
Effect of age on progesterone receptor expression, and osteoprogenitor proliferation and differentiation in female rat vertebral cell populations.
J. Endocrinol., August 1, 2006; 190(2): 261 - 270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-S. An, D. M. Selva, G. L. Hammond, A. Rivero-Muller, N. Rahman, and P. C. K. Leung
Steroid Receptor Coactivator-3 Is Required for Progesterone Receptor Trans-activation of Target Genes in Response to Gonadotropin-releasing Hormone Treatment of Pituitary Cells
J. Biol. Chem., July 28, 2006; 281(30): 20817 - 20824.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Dossus, F. Canzian, R. Kaaks, A. Boumertit, and E. Weiderpass
No Association between Progesterone Receptor Gene +331G/A Polymorphism and Endometrial Cancer.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1415 - 1416.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Karteris, S. Zervou, Y. Pang, J. Dong, E. W. Hillhouse, H. S. Randeva, and P. Thomas
Progesterone Signaling in Human Myometrium through Two Novel Membrane G Protein-Coupled Receptors: Potential Role in Functional Progesterone Withdrawal at Term
Mol. Endocrinol., July 1, 2006; 20(7): 1519 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely
Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity
Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. C. Condon, D. B. Hardy, K. Kovaric, and C. R. Mendelson
Up-Regulation of the Progesterone Receptor (PR)-C Isoform in Laboring Myometrium by Activation of Nuclear Factor-{kappa}B May Contribute to the Onset of Labor through Inhibition of PR Function
Mol. Endocrinol., April 1, 2006; 20(4): 764 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. Chen, N. Ohara, J. Wang, Q. Xu, J. Liu, A. Morikawa, H. Sasaki, S. Yoshida, D. A. Demanno, K. Chwalisz, et al.
A Novel Selective Progesterone Receptor Modulator Asoprisnil (J867) Inhibits Proliferation and Induces Apoptosis in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1296 - 1304.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Proia, B. W. Nannenga, L. A. Donehower, and N. L. Weigel
Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function
J. Biol. Chem., March 17, 2006; 281(11): 7089 - 7101.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J E Sanchez-Criado, J M. de las Mulas, C Bellido, V M Navarro, R Aguilar, J C Garrido-Gracia, M M Malagon, M Tena-Sempere, and A Blanco
Gonadotropin-secreting cells in ovariectomized rats treated with different oestrogen receptor ligands: a modulatory role for ER{beta} in the gonadotrope?
J. Endocrinol., February 1, 2006; 188(2): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke
Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zhang, A. M. Olland, Y. Zhu, J. Cohen, T. Berrodin, S. Chippari, C. Appavu, S. Li, J. Wilhem, R. Chopra, et al.
Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget
J. Biol. Chem., August 5, 2005; 280(31): 28468 - 28475.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos
A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
P. E. Schwartz
Progesterone Isoforms and Endometrial Cancer
Reproductive Sciences, May 1, 2005; 12(4): 219 - 221.
[PDF]


Home page
Reproductive SciencesHome page
E. E. Hanekamp, S. C.J.P. Gielen, P. E. De Ruiter, S. Chadha-Ajwani, F. J. Huikeshoven, C. W. Burger, J. A. Grootegoed, and L. J. Blok
Differences in Invasive Capacity of Endometrial Cancer Cell Lines Expressing Different Progesterone Receptor Isotypes: Possible Involvement of Cadherins
Reproductive Sciences, May 1, 2005; 12(4): 278 - 284.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
E. Smid-Koopman, L. C. M. Kuhne, E. E. Hanekamp, S. C.J.P. Gielen, P. E. De Ruiter, J. A. Grootegoed, T. J.M. Helmerhorst, C. W. Burger, A. O. Brinkmann, F. J. Huikeshoven, et al.
Progesterone-Induced Inhibition of Growth and Differential Regulation of Gene Expression in PRA- and/or PRB-Expressing Endometrial Cancer Cell Lines
Reproductive Sciences, May 1, 2005; 12(4): 285 - 292.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
Endocr. Rev., May 1, 2005; 26(3): 423 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Kurata, Y. Tabata, R. Shinei, Y. Iizuka, N. T. Masuda, K.-i. Kurihara, T. Okonogi, and S. Hoshiko
Endocrinological Properties of Two Novel Nonsteroidal Progesterone Receptor Modulators, CP8816 and CP8863
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 916 - 920.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications
Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Goldman, A. Weiss, I. Almalah, and E. Shalev
Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal
Mol. Hum. Reprod., April 1, 2005; 11(4): 269 - 277.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. J. Duffy
Predictive Markers in Breast and Other Cancers: A Review
Clin. Chem., March 1, 2005; 51(3): 494 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B.-S. An, J.-H. Choi, K.-C. Choi, and P. C. K. Leung
Differential Role of Progesterone Receptor Isoforms in the Transcriptional Regulation of Human Gonadotropin-Releasing Hormone I (GnRH I) Receptor, GnRH I, and GnRH II
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1106 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator
Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. U. Agoulnik, X.-W. Tong, D.-C. Fischer, K. Korner, N. E. Atkinson, D. P. Edwards, D. R. Headon, N. L. Weigel, and D. G. Kieback
A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer Risk
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6340 - 6347.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel
The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific
J. Biol. Chem., November 5, 2004; 279(45): 47298 - 47310.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Sumida, Y. Itahana, H. Hamakawa, and P.-Y. Desprez
Reduction of Human Metastatic Breast Cancer Cell Aggressiveness on Introduction of Either Form A or B of the Progesterone Receptor and Then Treatment with Progestins
Cancer Res., November 1, 2004; 64(21): 7886 - 7892.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Mulac-Jericevic and O. M Conneely
Reproductive tissue selective actions of progesterone receptors
Reproduction, August 1, 2004; 128(2): 139 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. M. Simmen, R. R. Eason, J. R. McQuown, A. L. Linz, T.-J. Kang, L. Chatman Jr., S. R. Till, Y. Fujii-Kuriyama, F. A. Simmen, and S. P. Oh
Subfertility, Uterine Hypoplasia, and Partial Progesterone Resistance in Mice Lacking the Kruppel-like Factor 9/Basic Transcription Element-binding Protein-1 (Bteb1) Gene
J. Biol. Chem., July 9, 2004; 279(28): 29286 - 29294.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Mesiano
Myometrial Progesterone responsiveness and the Control of Human Parturition
Reproductive Sciences, May 1, 2004; 11(4): 193 - 202.
[Abstract] [PDF]


Home page
Hum Reprod UpdateHome page
T. Maruo, N. Ohara, J. Wang, and H. Matsuo
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. A. Hopp, H. L. Weiss, S. G. Hilsenbeck, Y. Cui, D. C. Allred, K. B. Horwitz, and S. A. W. Fuqua
Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates
Clin. Cancer Res., April 15, 2004; 10(8): 2751 - 2760.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, E. Souvatzoglou, A. Vottero, N. Bhattacharyya, and G. P. Chrousos
Natural Glucocorticoid Receptor Mutants Causing Generalized Glucocorticoid Resistance: Molecular Genotype, Genetic Transmission, and Clinical Phenotype
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1939 - 1949.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. L. Arnett-Mansfield, A. deFazio, P. A. Mote, and C. L. Clarke
Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1429 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. Sereepapong, P. Chotnopparatpattara, S. Taneepanichskul, R. Markham, P. Russell, and I. S. Fraser
Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users
Hum. Reprod., March 1, 2004; 19(3): 547 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
F. Modugno
Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review
Am. J. Epidemiol., February 15, 2004; 159(4): 319 - 335.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Li and B. W. O'Malley
Unfolding the Action of Progesterone Receptors
J. Biol. Chem., October 10, 2003; 278(41): 39261 - 39264.
[Full Text] [PDF]